Where We Work
The USAID | Health Policy Initiative completed its work in Jordan on September 29, 2010.
Task Order I of the USAID | Health Policy Initiative in Jordan worked with local partners to devise and put into practice policies to increase access to high quality FP/RH and HIV programs.
HPI worked with the government and the Higher Population Council (HPC) to promote an enabling environment for FP/RH through the revision and extension of Jordan's Reproductive Health Action Plan (RHAP). With about one-fifth of the country's population in the 15–24 age range, the project also collaborated with Jordan's Higher Youth Council and the HPC to strengthen the role of young people in support of achieving national FP objectives.
HPI partnered with the National AIDS Program to support implementation of Jordan's HIV/AIDS Strategic Plan and strengthened local capacity by helping the National Institute of Training improve skills in policy analysis, development, and reform.
Evidence-based Advocacy Leads to Increased Funding for RH. Jordan's Higher Population Council used data from a cost analysis conducted by the project to successfully advocate for increased funding for RH programs. In June 2008, the Ministry of Planning and International Cooperation allocated funds for the Reproductive Health Action Plan 2008-2012 (RHAP II)—the second phase of Jordan's national RH program. The allocation increased funding for the program by 260 percent. RHAP II represents a new opportunity for addressing the barriers to the advancement of Jordan's national population strategy. Accurate costing of the plan will help Jordan to meet the plan's objectives and performance targets.
Government Negotiates Price Reduction for ARVs. In May 2007, the government successfully negotiated with GlaxoSmithKline and Abbott to reduce the price paid by the government for two ARVs: Combivir and Kaletra. While ARVs are provided to PLHIV for free, the dramatically reduced prices will help the government continue to meet treatment needs as donor funds phase out and more people become in need of treatment. HPI was instrumental in facilitating a multisectoral task force involving the government, PLHIV, and other partners who worked with the pharmaceutical companies to achieve the price reduction.